HIT (Health In Tech) YoY EBITDA Growth: -433.33% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HIT Health In Tech Inc HIT
19 GF Score
Price $0.88
! 3 Warning Signs
View Full Analysis

What is Health In Tech YoY EBITDA Growth?

Health In Tech HIT -4.32% 19 YoY EBITDA Growth is -433.33% as of Jun. 2026. GuruFocus rates HIT with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Health In Tech's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -433.33%.

Health In Tech's EBITDA per Share for the three months ended in Jun. 2026 was $-0.05.

Health In Tech YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Health In Tech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health In Tech YoY EBITDA Growth Chart

Health In Tech Annual Data
Trend Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
0.00 1,650.00 -48.57 25.00

Health In Tech Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.38 7.69 0.00 -381.82 -433.33
HIT
19GF Score
Health In Tech Inc HIT
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health In Tech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Health In Tech's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.045-0.036)/ | 0.036 |
=25.00 %

Health In Tech's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.05-0.015)/ | 0.015 |
=-433.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -433.33% mean?
Health In Tech (HIT) has a YoY EBITDA Growth of -433.33% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Health In Tech and its competitors.
Is Health In Tech's YoY EBITDA Growth too high?
Health In Tech's current YoY EBITDA Growth is -433.33%. Overall, Health In Tech has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Health In Tech's YoY EBITDA Growth compare to IDN and RSSS?
Health In Tech's YoY EBITDA Growth of -433.33% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Software company?
A good YoY EBITDA Growth depends on the Software industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Health In Tech and its competitors. Health In Tech's current YoY EBITDA Growth is -433.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health In Tech stock overvalued right now?
Health In Tech (HIT) has a current YoY EBITDA Growth of -433.33%. The current YoY EBITDA Growth is -433.33%. Health In Tech's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Health In Tech (HIT), the current YoY EBITDA Growth is -433.33% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health In Tech Business Description

Address 701 South Colorado Avenue, Suite 1, Stuart, FL, USA, 34994
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.
19GF Score

Get the complete analysis for HIT

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.88
Price